Revvity Inc (RVTY) Actualités

Form 144 - Report of proposed sale of securities

Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK

Revvity, Inc. (NYSE: RVTY), today announced an expansion of its work with Genomics England that leverages both organizations' expertise and...

Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells

The TotalSeq Phenocyte solution supports robust study of cellular heterogeneity and rare cell types in complex samples at a single cell level...

Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation

Revvity, Inc. (NYSE: RVTY), today announced it will host an Investor Day on Thursday, November 21, 2024 at 9:00 a.m. PT which will feature...

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Revvity Announces Financial Results for the Third Quarter of 2024

Revenue of $684 million; 2% reported growth; 2% organic growth GAAP EPS of $0.77; Adjusted EPS from continuing operations of $1.28 Raises full...

Revvity Board Declares Quarterly Dividend

The Board of Directors of Revvity, Inc. (NYSE: RVTY), today declared a regular quarterly dividend of $0.07 per share of common stock. This...

Revvity Introduces Transcribe AI: Revolutionizing Data Entry in Clinical Laboratories

Enables transcription of handwritten test request forms to digitized format Utilizes innovative AI for higher accuracy and efficiency Data is...